Cargando…

4E Interacting Protein as a Potential Novel Drug Target for Nucleoside Analogues in Trypanosoma brucei

Human African trypanosomiasis is a neglected parasitic disease for which the current treatment options are quite limited. Trypanosomes are not able to synthesize purines de novo and thus solely depend on purine salvage from the host environment. This characteristic makes players of the purine salvag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mabille, Dorien, Cardoso Santos, Camila, Hendrickx, Rik, Claes, Mathieu, Takac, Peter, Clayton, Christine, Hendrickx, Sarah, Hulpia, Fabian, Maes, Louis, Van Calenbergh, Serge, Caljon, Guy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069773/ https://www.ncbi.nlm.nih.gov/pubmed/33924674 http://dx.doi.org/10.3390/microorganisms9040826

Ejemplares similares

Nucleoside analogues for the treatment of animal trypanosomiasis
por: Mabille, Dorien, et al.
Publicado: (2022)

6-Methyl-7-deazapurine nucleoside analogues as broad-spectrum antikinetoplastid agents
por: Lin, Cai, et al.
Publicado: (2021)

Development of Novel Isoindolone‐Based Compounds against Trypanosoma brucei rhodesiense
por: Silva, Daniel G., et al.
Publicado: (2021)

Combining tubercidin and cordycepin scaffolds results in highly active candidates to treat late-stage sleeping sickness
por: Hulpia, Fabian, et al.
Publicado: (2019)

Phenotypic Evaluation of Nucleoside Analogues against Trypanosoma cruzi Infection: In Vitro and In Vivo Approaches
por: Fiuza, Ludmila F. de A., et al.
Publicado: (2022)

Neutrophils enhance early Trypanosoma brucei infection onset
por: Caljon, Guy, et al.
Publicado: (2018)

Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum
por: Hendrickx, Sarah, et al.
Publicado: (2017)

Comparison of Bioluminescent Substrates in Natural Infection Models of Neglected Parasitic Diseases
por: Hendrickx, Sarah, et al.
Publicado: (2022)

Exploring the purine core of 3′-C-ethynyladenosine (EAdo) in search of novel nucleoside therapeutics
por: Hulpia, Fabian, et al.
Publicado: (2016)

Interferon Alpha Favors Macrophage Infection by Visceral Leishmania Species Through Upregulation of Sialoadhesin Expression
por: Van Bockstal, Lieselotte, et al.
Publicado: (2020)

Synthesis of a 3′-C-ethynyl-β-d-ribofuranose purine nucleoside library: Discovery of C7-deazapurine analogs as potent antiproliferative nucleosides
por: Hulpia, Fabian, et al.
Publicado: (2018)

Impact of pulmonary African trypanosomes on the immunology and function of the lung
por: Mabille, Dorien, et al.
Publicado: (2022)

SUMOylation in Trypanosoma brucei
por: Klein, Cornelia Andrea, et al.
Publicado: (2013)

In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series
por: Van den Kerkhof, M., et al.
Publicado: (2018)

The Dermis as a Delivery Site of Trypanosoma brucei for Tsetse Flies
por: Caljon, Guy, et al.
Publicado: (2016)

Cloning and Characterization of Trypanosoma congolense and T. vivax Nucleoside Transporters Reveal the Potential of P1-Type Carriers for the Discovery of Broad-Spectrum Nucleoside-Based Therapeutics against Animal African Trypanosomiasis
por: Ungogo, Marzuq A., et al.
Publicado: (2023)

The Trypanosoma cruzi TcrNT2 Nucleoside Transporter Is a Conduit for the Uptake of 5-F-2′-Deoxyuridine and Tubercidin Analogues
por: Aldfer, Mustafa M., et al.
Publicado: (2022)

In-depth comparison of cell-based methodological approaches to determine drug susceptibility of visceral Leishmania isolates
por: Hendrickx, Sarah, et al.
Publicado: (2019)

Evaluation of a pan-Leishmania SL RNA qPCR assay for parasite detection in laboratory-reared and field-collected sand flies and reservoir hosts
por: Pareyn, Myrthe, et al.
Publicado: (2020)

MIF Contributes to Trypanosoma brucei Associated Immunopathogenicity Development
por: Stijlemans, Benoît, et al.
Publicado: (2014)

Antileishmanial Aminopyrazoles: Studies into Mechanisms and Stability of Experimental Drug Resistance
por: Van den Kerkhof, M., et al.
Publicado: (2020)

The effect of the sugar metabolism on Leishmania infantum promastigotes inside the gut of Lutzomyia longipalpis: A sweet relationship?
por: Hendrickx, Sarah, et al.
Publicado: (2022)

Immune Evasion Strategies of Trypanosoma brucei within the Mammalian Host: Progression to Pathogenicity
por: Stijlemans, Benoît, et al.
Publicado: (2016)

Acyclic nucleoside phosphonates with adenine nucleobase inhibit Trypanosoma brucei adenine phosphoribosyltransferase in vitro
por: Doleželová, Eva, et al.
Publicado: (2021)

Identification of Resistance Determinants for a Promising Antileishmanial Oxaborole Series
por: Van den Kerkhof, Magali, et al.
Publicado: (2021)

1-(1-Arylethylpiperidin-4-yl)thymine Analogs as Antimycobacterial TMPK Inhibitors
por: Jian, Yanlin, et al.
Publicado: (2020)

Trypanosoma brucei Modifies the Tsetse Salivary Composition, Altering the Fly Feeding Behavior That Favors Parasite Transmission
por: Van Den Abbeele, Jan, et al.
Publicado: (2010)

A Toxoplasma gondii Oxopurine Transporter Binds Nucleobases and Nucleosides Using Different Binding Modes
por: Campagnaro, Gustavo D., et al.
Publicado: (2022)

Development of Simplified Heterocyclic Acetogenin Analogues as Potent and Selective Trypanosoma brucei Inhibitors
por: Florence, Gordon J., et al.
Publicado: (2016)

The Cell Cycle Regulated Transcriptome of Trypanosoma brucei
por: Archer, Stuart K., et al.
Publicado: (2011)

Evaluating drug resistance in visceral leishmaniasis: the challenges
por: HENDRICKX, S, et al.
Publicado: (2018)

Interactions of the Trypanosoma brucei brucei zinc-finger-domain protein ZC3H28
por: Bishola Tshitenge, Tania, et al.
Publicado: (2022)

Role of the stage-regulated nucleoside transporter TbNT10 in differentiation and adenosine uptake in Trypanosoma brucei
por: Spoerri, Iris, et al.
Publicado: (2007)

Nucleoside analogue activators of cyclic AMP-independent protein kinase A of Trypanosoma
por: Bachmaier, Sabine, et al.
Publicado: (2019)

Trypanosoma evansi is alike to Trypanosoma brucei brucei in the subcellular localisation of glycolytic enzymes
por: Moreno, S Andrea, et al.
Publicado: (2015)

Luminescent multiplex viability assay for Trypanosoma brucei gambiense
por: Van Reet, Nick, et al.
Publicado: (2013)

Wild chimpanzees are infected by Trypanosoma brucei
por: Jirků, Milan, et al.
Publicado: (2015)

Evaluation of In Vitro Activity of Essential Oils against Trypanosoma brucei brucei and Trypanosoma evansi
por: Habila, Nathan, et al.
Publicado: (2010)

C-Terminal Mutants of Apolipoprotein L-I Efficiently Kill Both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense
por: Lecordier, Laurence, et al.
Publicado: (2009)

De Novo Genome Assembly Shows Genome Wide Similarity between Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense
por: Sistrom, Mark, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9nqgp0v7csnaoa8imq7r1emslg